These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2745033)

  • 21. CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma.
    Quaranta M; Lorusso V; Coviello M; Micelli G; Casamassima A
    Int J Cancer Suppl; 1988; 3():68-70. PubMed ID: 3209302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CA 125 in ovarian cancer.
    van der Burg ME; Lammes FB; Verweij J
    Neth J Med; 1992 Feb; 40(1-2):36-51. PubMed ID: 1579185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer.
    Berek JS; Chung C; Kaldi K; Watson JM; Knox RM; Martínez-Maza O
    Am J Obstet Gynecol; 1991 Apr; 164(4):1038-42; discussion 1042-3. PubMed ID: 2014824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors.
    Li XG; Chen DX; Schwartz PE; Yang Z
    Gynecol Oncol; 1989 Mar; 32(3):327-30. PubMed ID: 2920953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer.
    Zurawski VR; Sjovall K; Schoenfeld DA; Broderick SF; Hall P; Bast RC; Eklund G; Mattsson B; Connor RJ; Prorok PC
    Gynecol Oncol; 1990 Mar; 36(3):299-305. PubMed ID: 2318438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CA 125 tumour-associated antigen: a review of the literature.
    Jacobs I; Bast RC
    Hum Reprod; 1989 Jan; 4(1):1-12. PubMed ID: 2651469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serum CA 125 levels in the monitoring of ovarian cancer.
    Vergote IB; Børmer OP; Abeler VM
    Am J Obstet Gynecol; 1987 Jul; 157(1):88-92. PubMed ID: 2440307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
    Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
    Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of CA 125 in advanced ovarian cancer.
    Mogensen O
    Gynecol Oncol; 1992 Mar; 44(3):207-12. PubMed ID: 1541430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
    Plante M; Wong GY; Nisselbaum JS; Almadrones L; Hoskins WJ; Rubin SC
    Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CA 125 in the early diagnosis of progressive disease in ovarian cancer.
    van der Burg ME; Lammes FB; Verweij J
    Ann Oncol; 1990 Jul; 1(4):301-2. PubMed ID: 2265140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
    Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
    Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CA 125 reliability in predicting ovarian cancer recurrence.
    Zanaboni F; Presti M; Scarfone G; Bolis G
    Tumori; 1989 Feb; 75(1):69-71. PubMed ID: 2711479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study.
    Bai H; Sha G; Xiao M; Gao H; Cao D; Yang J; Chen J; Wang Y; Zhang Z; Shen K
    Oncotarget; 2016 Mar; 7(13):15566-76. PubMed ID: 26863639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CA 125 in monitoring chemotherapy of the patients with ovarian cancer.
    Markowska J; Kojczynski Z; Szewierski Z; Manys G
    Eur J Gynaecol Oncol; 1990; 11(3):209-14. PubMed ID: 2209640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.
    Onetto M; Bruzzone M; Conte PF; Ruvolo M; Conio A; Chiara S; Falcone A; Bentivoglio G; Serra GE; Paganuzzi M
    Oncology; 1989; 46(2):117-22. PubMed ID: 2710476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of CA 125 as a marker of ovarian cancer.
    Markowska J; Manys G; Kubaszewska M
    Eur J Gynaecol Oncol; 1992; 13(4):360-5. PubMed ID: 1516589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CA-125 monitoring in the management of ovarian cancer.
    Bruzzone M; Onetto M; Campora E; Chiara S; Oliva C; Guido T; Merlini L; Parodi S; Bentivoglio G; Ventrella W
    Anticancer Res; 1990; 10(5A):1353-9. PubMed ID: 2241112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
    Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL
    Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.